Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Forbes Earnings Preview: Sanofi (SNY)
Forbes
Tuesday, July 30, 2013 - 1:59pm
tags:
earnings, Sanofi
Can Biotech Earnings Hold Up?
Forbes
Tuesday, July 30, 2013 - 1:31pm
tags:
biotech, earnings
Vivus Weight-Loss Pill Scripts Are Surging
TheStreet.com
Tuesday, July 30, 2013 - 1:30pm
tags:
Vivus, obesity, Qsymia, Arena Pharmaceuticals, Orexigen
Earnings Preview: Amgen shares up sharply in July ahead of Q2 results
The Fly on the Wall
Tuesday, July 30, 2013 - 1:27pm
tags:
earnings, Amgen
Vertex Motors Down Cystic Fibrosis Highway
TheStreet.com
Tuesday, July 30, 2013 - 1:23pm
tags:
Vertex Pharmaceuticals, cystic fibrosis, Kalydeco
Patient taking Novartis MS pill developed rare disease
Reuters
Tuesday, July 30, 2013 - 1:20pm
tags:
Novartis, MS, multiple sclerosis, Gilenya
Earnings for Teva Pharmaceutical Industries (TEVA) Expected to Fall
Forbes
Tuesday, July 30, 2013 - 1:18pm
tags:
Teva, earnings
More Bad News For Novartis Blood Pressure Drug
Forbes
Tuesday, July 30, 2013 - 1:12pm
tags:
Novartis, Diovan, antihypertensives
Is Pfizer’s Internal Split a Sign a Breakup Is Coming?
Wall St. Cheat Sheet
Tuesday, July 30, 2013 - 1:11pm
tags:
Pfizer
KCI to Acquire Systagenix
CP Wire
Tuesday, July 30, 2013 - 1:06pm
tags:
KCI, M&A, Systagenix, devices, wound care
United Therapeutics Reports Record Earnings, Guides Higher, And Is Still Cheap
Seeking Alpha
Tuesday, July 30, 2013 - 12:00pm
tags:
United Therapeutics, earnings
Will Arena Earnings Finally Explode Higher?
Motley Fool
Tuesday, July 30, 2013 - 11:56am
tags:
Arena Pharmaceuticals, earnings
Inovio May Prove To Be Merck's Solution
Seeking Alpha
Tuesday, July 30, 2013 - 11:54am
tags:
Inovio, Merck
Isis Pharmaceuticals Earns $2 Million from GSK for the Advancement of ISIS-TTR Rx
Yahoo
Tuesday, July 30, 2013 - 11:47am
tags:
GSK, Isis Pharmaceuticals, ISIS-TTRRx, antisense
BioPharma Catalyst Trade Pick Of The Week: Biodel
Seeking Alpha
Tuesday, July 30, 2013 - 11:43am
tags:
MannKind, Eli Lilly, Biodel, Astex
Are 90% Of FDA Drugs Approved In Last 30 Years No More Effective Than Existing Drugs?
Forbes
Tuesday, July 30, 2013 - 11:39am
tags:
drug approvals, FDA
Why Glaxo’s China scandal needed to happen
CNBC
Tuesday, July 30, 2013 - 11:37am
tags:
China, GSK
2 Keys to Success for This Diabetes Drug's Second Chance
Motley Fool
Tuesday, July 30, 2013 - 11:35am
tags:
diabetes, AstraZeneca, Bristol-Myers Squibb, Forxiga
Pfizer Beats Estimates as Company Prepares for Split
Bloomberg
Tuesday, July 30, 2013 - 10:58am
tags:
earnings, Pfizer, reorganization
Merck Second-Quarter Profit Falls as Generics Erode Sales
Bloomberg
Tuesday, July 30, 2013 - 10:58am
tags:
Merck, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.